Literature DB >> 16378590

Ectopic expression of a polyalanine expansion mutant of poly(A)-binding protein N1 in muscle cells in culture inhibits myogenesis.

Qishan Wang1, Jnanankur Bag.   

Abstract

Oculopharyngeal muscular dystrophy (OPMD) is an adult-onset dominant genetic disease caused by the expansion of a GCG trinucleotide repeat that encodes the polyalanine tract at the N-terminus of the nuclear poly(A)-binding protein (PABPN1). Presence of intranuclear inclusions (INIs) containing PABPN1 aggregates in the skeletal muscles is the hallmark of OPMD. Here, we show that ectopic expression of the mutant PABPN1 produced INIs in a muscle cell culture model and reduced expression of several muscle-specific proteins including alpha-actin, slow troponin C, muscle creatine kinase, and two myogenic transcription factors, myogenin and MyoD. However, the levels of two upstream regulators of the MyoD gene, the Myf-5 and Pax3/7, were not affected, but both proteins co-localized with the PABPN1 aggregates in the mutant PABPN1 overexpressing cells. In these cells, although myogenin and MyoD levels were reduced, these two transcription factors did not co-localize with the mutant PABPN1 aggregates. Therefore, sequestration of Myf5 and Pax3/7 by the mutant PABPN1 aggregates was a specific effect on these factors. Our results suggest that trapping of these two important myogenic determinants may interfere with an early step in myogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16378590     DOI: 10.1016/j.bbrc.2005.12.078

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Modeling oculopharyngeal muscular dystrophy in myotube cultures reveals reduced accumulation of soluble mutant PABPN1 protein.

Authors:  Vered Raz; Samantha Routledge; Andrea Venema; Hellen Buijze; Erik van der Wal; Seyedyahya Anvar; Kirsten R Straasheijm; Rinse Klooster; Michael Antoniou; Silvère M van der Maarel
Journal:  Am J Pathol       Date:  2011-08-18       Impact factor: 4.307

2.  Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology.

Authors:  Katherine E Vest; Brittany L Phillips; Ayan Banerjee; Luciano H Apponi; Eric B Dammer; Weiting Xu; Dinghai Zheng; Julia Yu; Bin Tian; Grace K Pavlath; Anita H Corbett
Journal:  Hum Mol Genet       Date:  2017-09-01       Impact factor: 6.150

3.  Functional impact of an oculopharyngeal muscular dystrophy mutation in PABPN1.

Authors:  Maricela García-Castañeda; Ana Victoria Vega; Rocío Rodríguez; Maria Guadalupe Montiel-Jaen; Bulmaro Cisneros; Angel Zarain-Herzberg; Guillermo Avila
Journal:  J Physiol       Date:  2017-04-25       Impact factor: 5.182

Review 4.  PABPN1: molecular function and muscle disease.

Authors:  Ayan Banerjee; Luciano H Apponi; Grace K Pavlath; Anita H Corbett
Journal:  FEBS J       Date:  2013-05-24       Impact factor: 5.542

5.  Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts.

Authors:  Jouni Vesa; Hailing Su; Giles D Watts; Sabine Krause; Maggie C Walter; Barbara Martin; Charles Smith; Douglas C Wallace; Virginia E Kimonis
Journal:  Neuromuscul Disord       Date:  2009-10-13       Impact factor: 4.296

6.  An Antibody to Detect Alanine-Expanded PABPN1: A New Tool to Study Oculopharyngeal Muscular Dystrophy.

Authors:  Katherine E Vest; Luciano H Apponi; Ayan Banerjee; Grace K Pavlath; Anita H Corbett
Journal:  J Neuromuscul Dis       Date:  2015-10-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.